Prevacid Solutablansoprazole

According to the FDA label: Lansoprazole delayed-release capsules are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults ( 1.1 ) Eradication of H.

104,314 adverse event reports submitted to the FDA (2003–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Prevacid Solutab in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Prevacid Solutab adverse event reports by reporter sex
SexReports
Female51,364
Male42,425
Unknown255

By Age Group

View age group data as a table
Prevacid Solutab adverse event reports by reporter age group
Age groupReports
0-173,275
18-343,663
35-4910,086
50-6420,007
65-7420,277
75+23,866

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Prevacid Solutab. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Prevacid Solutab adverse event reports by reported outcome
OutcomeReports
Other Serious60,747
Hospitalization49,369
Death13,070
Life-Threatening10,731
Disability7,808
Non-Serious7,675

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Prevacid Solutab. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Prevacid Solutab adverse event reports by year
YearReports
20031
20041,299
20051,406
20061,113
20071,294
20081,659
20091,688
20101,874
20112,666
20123,291
20132,967
20143,525
20155,024
20165,891
20175,546
20188,311
201910,615
20207,743
20216,772
20226,865
20237,549
20248,127
20257,385
2026 (partial)1,703

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Prevacid Solutab

In FDA adverse event reports that mention Prevacid Solutab, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026